In contrast to normal prostatic epithelial cells, which are not able to regenerate and grow in an androgen-deprived state, prostate cancer cells almost always manage to acquire an androgen-independent ...
Continuation of androgen deprivation therapy for an additional 24 months improves all disease end points during 15 years of follow-up compared with short-term androgen deprivation in men with locally ...